Generics week continues, as the FDA approved generic versions of the antidepressant Zoloft (by Pfizer).
Teva will begin distributing 25-, 50-, and 100-mg sertraline tablets later this month, and Roxane Laboratories will sell a liquid form of the drug. The generic forms are “authorized generics”, meaning Pfizer gave the generic manufacturers exclusivity rights to the drug in order to help cut the drug company’s losses.
Last month, Teva also received generic approval for Lexapro, but that release is pending litigation from the brand’s manufacturer Forest Laboratories.
« New drug for treating macular degeneration FDA turns 100! »
